Iron Dosing Pilot Study Using Model Predictive Control
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03633656|
Recruitment Status : Not yet recruiting
First Posted : August 16, 2018
Last Update Posted : August 16, 2018
|Condition or disease||Intervention/treatment||Phase|
|Renal Insufficiency, Chronic Anemia, Iron Deficiency Anemia of Chronic Kidney Disease||Device: Model predictive control||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||10 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Device Feasibility|
|Official Title:||Iron Dosing Pilot Study Using Model Predictive Control|
|Estimated Study Start Date :||October 2018|
|Estimated Primary Completion Date :||March 2019|
|Estimated Study Completion Date :||March 2019|
Model predictive control recommendation of iron dosing in combination with an erythropoietic stimulating agent.
Device: Model predictive control
Computer aided dose selection for the treatment of iron deficient anemia.
- Percentage of tsat values within range [ Time Frame: Monthly for 6 months ]Tsat is measured as a percent saturation, desired range is 20 to 50%
- Iron dose over ride by physician [ Time Frame: Monthly for 6 months ]Number of recommended iron doses that the prescribing physician altered.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03633656
|Contact: Michael Brier, PhDfirstname.lastname@example.org|
|United States, Kentucky|
|University of Louisville||Not yet recruiting|
|Louisville, Kentucky, United States, 40202|
|Contact: Michael Brier, PhD 502-852-5757 email@example.com|
|Principal Investigator:||Alfred Jacobs, MD||University of Louisville|